Clinical Trial Update: Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

A six-month Phase 3 trial evaluating the efficacy and safety of inhaled insulin in Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED